The senior vice president of immunology at Cellectis discussed the company’s investigational dual-targeted CAR-T therapy for B-cell malignancies.
Laurent Poirot, PhD
Advertisement
Articles by Laurent Poirot, PhD
Advertisement
Latest Updated Articles
Laurent Poirot, PhD, on the FDA’s IND Clearance for UCART20x22Published: August 25th 2022 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Hits Atara Biotherapeutics’ T-Cell Immunotherapy Tabelecleucel for EBV+ PTLD With Second CRL
2
Steven W. Pipe, MD, on Integrating Gene Therapy into Clinical Care for Hemophilia B
3
Brian Lin, PhD, on Using Genetics, Biomarkers, and Clinical Trial Readiness to Enhance ALS Care
4
Data Roundup: December 2025 Features Updates from ASH and CTAD
5